Global News Aggregator
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already…
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co.,…
Wall Street mounted a relief rally Tuesday, following three straight sessions dominated by the woes of now-collapsed Silicon Valley Bank. Confronted with the ensuing spike in market volatility, we sought…
As investors worry about greater market volatility looming in 2023, Trivariate Research offers up some cheap, quality stocks that can be used to play defense. Stocks are off to a…
The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in…
Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of…
Investors do not need to abandon their energy plays even though oil prices have fallen in recent weeks, according to Sarat Sethi. The DCLA portfolio manager said on ” Squawk…
Investors may want to consider JPMorgan’s Equity Premium Income Fund ETF in order to get more reliable gains in the current volatile market environment. According to the firm, the ETF…
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America.…
Check out the companies making headlines in premarket trading Wednesday. Starbucks – Shares of Starbucks gained nearly 1% after the company boosted its long-term forecast and said it expects double-digit…